Why Healthcare Data Security Demands Special Attention
Healthcare organizations handle some of the most sensitive personal data that exists: medical histories, genetic information, mental health records, substance use history, sexual health data, and financial information tied to health insurance. This data is subject to specific regulatory protections in many jurisdictions and is a target for cybercriminals. The Verizon 2023 Data Breach Investigations Report recorded 433 breaches in Healthcare, behind Public Administration at 582 and Finance at 477. The report therefore does not support calling Healthcare the most breached industry that year.
Depending on the architecture and service roles, adopting an AI tool may introduce new places where sensitive clinical data is processed, transmitted, or stored, including by a third party. Responsibility is shared according to role: the institution retains its statutory and clinical-governance duties, clinicians retain responsibility for clinical decisions, and the vendor is responsible for the controls and contractual commitments within its service scope. The exact allocation depends on jurisdiction, deployment, data flow, and contract.
This article is a practical guide to the security questions that matter most when evaluating healthcare AI vendors.
The Regulatory Landscape
Before evaluating specific security controls, it is important to understand the regulatory context:
Indonesia: UU PDP (Undang-Undang Perlindungan Data Pribadi)
Indonesia's Personal Data Protection Law (UU No. 27/2022) was enacted in 2022 and treats health data as specific personal data. Under Article 46(1), a personal data controller must provide written notice to the data subject and the authority no later than 3 x 24 hours after a failure to protect personal data occurs. That clock applies to this written-notification duty; it is not a universal deadline for every security incident.
Singapore: PDPA and applicable healthcare requirements
Singapore's Personal Data Protection Act applies to personal-data handling. The Health Information Act 2026 was enacted in February 2026, but its duties are not current obligations: the Act commences on dates appointed by Gazette, and the Ministry of Health has said licensed health providers will be brought in progressively from September 2027. Current PDPA and applicable HCSA or other MOH duties should therefore be assessed separately from HIA implementation planning. For a breach assessed as notifiable under the PDPA, the organization must notify the PDPC as soon as practicable and no later than three calendar days after completing its assessment; affected individuals must be notified as soon as practicable. This is not a blanket three-day clock from the occurrence of every breach. See the PDPC notification guidance.
Hong Kong: PDPO and PCPD Guidance
Hong Kong's Personal Data (Privacy) Ordinance and data protection principles continue to apply to personal data handling. The cross-border transfer restriction in section 33 is not yet in operation. The PCPD recommends due diligence to ensure comparable protection and provides model contractual clauses for cross-border transfers; it does not present section 33 as a currently operative statutory restriction. See the PCPD guidance.
ISO Standards
International standards provide a vendor-agnostic framework for security assessment. The most relevant for healthcare AI vendors are ISO 27001 (Information Security Management System), ISO 27701 (Privacy Information Management), ISO 13485 (Medical Devices Quality Management, for AI systems that qualify as medical devices), and ISO 9001 (Quality Management System).
Key Security Questions for AI Vendors
1. Data Processing Architecture
Where is clinical data processed? Cloud processing raises questions about provider, region, support access, subprocessors, and transfer arrangements. On-premise deployment avoids reliance on a vendor-operated cloud environment but adds local responsibilities for hardening, patching, identity and access, backup, resilience, monitoring, and physical security. Hybrid architectures divide those responsibilities and must be assessed end to end.
The key questions are: what deployment options actually exist, where each class of data is processed and stored, who can access it for operations or support, and what commitments are contractual? Data location is one input to the analysis; it does not by itself determine which laws, clinical duties, or security obligations apply.
2. Data Minimization and Retention
Does the AI system require access to the full patient record, or only the specific fields needed for its function? Data minimization — processing only the data actually needed — reduces exposure. Similarly, clear data retention policies (how long does the vendor store any data they process?) and secure deletion procedures are essential.
3. Encryption Standards
Data in transit should use modern encrypted transport that meets the institution's approved security baseline and applicable requirements; TLS 1.3 may be preferred where the connected systems support it, but it is not a universal legal threshold. Access to encryption keys should be controlled and reviewable. Ask vendors to specify protocols, cipher policy, key-management responsibilities, and any contractual data-location commitments.
4. Access Controls
Who within the vendor organization can access patient data, for which purpose, and under whose authorization? Role-based access, strong authentication, and periodic access review are common controls, but the required design depends on the deployment and risk assessment. Some architectures can reduce vendor visibility into content; whether that is technically feasible and appropriate must be verified for the actual workflow rather than treated as a universal requirement.
5. Audit Logging
Audit evidence should be proportionate to the workflow and the duties that apply. Confirm which access, AI proposal, approval, export, and writeback events are recorded; who can view or export that evidence; how integrity and retention are managed; and which records the institution receives. Do not assume every event is logged, that a log is tamper-proof, or that the same scope is legally required in every jurisdiction.
6. Incident Response
What is the vendor's incident response procedure, and how quickly are healthcare organization customers notified? In Indonesia, Article 46(1) gives the controller no more than 3 x 24 hours after a failure to protect personal data to provide the required written notice to the data subject and the authority. In Singapore, the three-calendar-day limit for notifying the PDPC starts after the organization completes its assessment and determines that the breach is notifiable; affected individuals must be notified as soon as practicable. Neither rule is a universal incident-handling deadline. A vendor's contractual notice and response SLA should give the responsible healthcare organization enough time and information to meet the duties that actually apply.
7. Third-Party Assessments
ISO 27001 certificates, SOC 2 Type II reports, and penetration-testing results can provide scoped third-party evidence about particular controls, periods, and systems. Buyers should request and review the scope, issuer, dates, findings, and limitations rather than treat a credential as blanket validation.
Micromeet builds governed healthcare AI infrastructure for continuous care. Clinicians and authorized staff review consequential outputs.
What ISO 27001 Actually Means
ISO 27001 is frequently cited as a security credential by technology vendors, including healthcare AI companies. It is worth understanding precisely what it certifies and what it does not.
ISO 27001 certification means that a third-party certification body has assessed the organization's Information Security Management System (ISMS) against the standard's requirements, including risk assessment, controls, and continual improvement. ISO states that certification bodies may seek accreditation, but accreditation is not compulsory. Buyers should verify the certification body, its accreditation status, and the certificate's scope separately through ISO's certification guidance.
It does not mean that the organization has never had a security incident, that all possible vulnerabilities have been addressed, or that the certification scope covers all systems the organization operates. Certification scope documentation should be requested to understand exactly what is covered.
Building Vendor Security Assessment into Procurement
One practical procurement approach is to use a standardized, risk-based security questionnaire for healthcare technology vendors, covering the questions above before contract signing. Organizations like HIMSS (Healthcare Information and Management Systems Society) publish vendor security assessment frameworks that can be adapted for local regulatory contexts.
Two companion checklists can help structure that review: questions a CIO should ask before buying healthcare AI and how clinics govern patient health data under Indonesia's UU PDP.
Security assessment should continue over the life of a technology relationship. Review cadence, monitoring of vendor advisories, assurance evidence, and contractual audit or information rights should be set according to risk, applicable law, institutional policy, and contract.
This is the assessment discipline Micromeet applies to its own platform. Micromeet — AI for governed healthcare treats security and governance as product requirements, not add-ons. For enabled workflows, Micromeet Care Workspace supports configured access roles, approval states, and review history. The institution and Micromeet must still verify the exact data processed, source of truth, processing location, support access, audit evidence, export path, writeback path, and responsibility split for the deployment. Clinical decisions and final clinical approval remain with authorized professionals; Micromeet remains responsible for the controls and commitments within its agreed service scope. AI writes. Doctors decide. We encourage hospital IT teams to put Micromeet through exactly the assessment described above.
FAQ
What security questions should hospital IT teams ask a healthcare AI vendor? Seven areas cover much of the assessment: data flows, processing locations, support access, and contractual commitments; data minimization and retention; encrypted transport against the institution's approved baseline; access controls; the exact audit evidence and export path available to the institution; incident response aligned with applicable duties; and relevant independent assessments. Responsibility must be mapped among the institution, clinicians, vendor, and subprocessors for the actual jurisdiction and deployment.
What does ISO 27001 certification actually prove? It shows that a third-party certification body assessed the organization's Information Security Management System against ISO 27001. Accreditation of that certification body is not compulsory under ISO guidance, so buyers should verify the body, its accreditation status, and the certificate scope separately. Certification does not prove the organization has never had an incident, that all vulnerabilities are addressed, or that every system is covered.
What data protection laws apply to healthcare AI in Southeast Asia? Indonesia's UU PDP treats health data as specific personal data; Article 46(1) requires a controller to notify the data subject and the authority in writing no later than 3 x 24 hours after a failure to protect personal data. In Singapore, the PDPA and applicable HCSA or other current MOH duties must be assessed for the service and implementation. The HIA was enacted in February 2026, but MOH says its duties will begin progressively from September 2027, so they should not be mixed with current obligations. A PDPA-notifiable breach must be reported to the PDPC as soon as practicable and no later than three calendar days after assessment. In Hong Kong, the PDPO and data protection principles apply, but section 33 is not yet in operation; the PCPD recommends comparable protection and model contractual clauses for cross-border transfers.
Should clinical AI data be processed in the cloud or on-premise? It depends on the facility's applicable duties, architecture, and risk posture. Cloud processing raises provider, region, access, subprocessor, and transfer questions. On-premise avoids reliance on a vendor-operated cloud environment but adds local security and operational responsibilities. Data location alone does not decide which laws apply. Assess the full data flow, responsibilities, controls, and contractual commitments.
How does Micromeet approach data security in its healthcare AI? Micromeet treats security governance as a product requirement. For enabled workflows, Micromeet Care Workspace supports configured access roles, approval states, and review history, while exact data location, audit evidence, export, connections, and writeback are verified per institution. Authorized professionals retain clinical decisions; Micromeet is responsible for controls and commitments within its agreed service scope. Hospital IT teams should evaluate Micromeet with the same due diligence described here.
